Multiplex quantification of C-terminal alpha-1-antitrypsin peptides provides a novel approach for characterizing systemic inflammation

• Published in: Scientific reports 2022-03, Vol.12 (1), p.3844-3844, Article 3844
• Main Authors: Bigalke, Arite, Sponholz, Christoph, Schnabel, Claudia, Bauer, Michael, Kiehntopf, Michael
• Format: Article
• Language: English
• Subjects: 692/4017; 692/53; 692/699; Allergies; alpha 1-Antitrypsin - chemistry; Chromatography, Liquid; Enzymatic activity; Heparin; Humanities and Social Sciences; Humans; Immune response; Inflammation; Lithium; multidisciplinary; Peptides; Peptides - chemistry; Science; Science (multidisciplinary); Sepsis; Serine proteinase; Tandem Mass Spectrometry
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-022-07752-w

C-terminal peptides (CAAPs) of the highly abundant serine protease alpha-1-antitrypsin (A1AT) have been identified at various lengths in several human materials and have been proposed to serve as putative biomarkers for a variety of diseases. CAAPs are enzymatically formed and these enzymatic activities are often associated with excessive immune responses ( e.g. sepsis, allergies). However, most of those CAAPs have been either detected using in vitro incubation experiments or in human materials which are not easily accessible. To gain a comprehensive understanding about the occurrence and function of CAAPs in health and disease, a LC–MS/MS method for the simultaneous detection of nine CAAPs was developed and validated for human plasma (EDTA and lithium-heparin) and serum. Using this newly developed method, we were able to detect and quantify five CAAPs in healthy individuals thereby providing an initial proof for the presence of C36, C37, C40 and C44 in human blood. Concentrations of four CAAPs in a clinical test cohort of patients suffering from sepsis were significantly higher compared to healthy controls. These results reveal that in addition to C42 other fragments of A1AT seem to play a crucial role during systemic infections. The proposed workflow is simple, rapid and robust; thus this method could be used as diagnostic tool in routine clinical chemistry as well as for research applications for elucidating the diagnostic potential of CAAPs in numerous diseases. To this end, we also provide an overview about the current state of knowledge for CAAPs identified in vitro and in vivo.